Global Cord Blood (NYSE:CO) Shares Down 2% – Time to Sell?

Global Cord Blood Co. (NYSE:CO – Get Free Report)’s share price dropped 2% during mid-day trading on Tuesday. The stock traded as low as $0.9510 and last traded at $0.9510. Approximately 50,000 shares traded hands during trading, a decline of 77% from the average daily volume of 216,519 shares. The stock had previously closed at $0.97.

Global Cord Blood Stock Performance

The firm has a market cap of $115.60 million, a P/E ratio of 1.49 and a beta of 0.16. The company has a 50 day moving average of $0.95 and a 200 day moving average of $0.96.

Global Cord Blood Company Profile

(Get Free Report)

Global Cord Blood Corporation is a cord blood banking services provider focused on China. Through its operating subsidiaries, the company collects, processes, tests and stores umbilical cord blood, which contains stem cells that may be used in certain medical treatments. The company offers families the option to preserve cord blood for potential future use and provides related laboratory and storage services. Its operations have served licensed markets including Beijing, Guangdong and Zhejiang. Previously known as China Cord Blood Corporation, the company adopted the Global Cord Blood Corporation name in 2019.

Featured Stories

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.